These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35163478)

  • 21. Visfatin promotes cell and tumor growth by upregulating Notch1 in breast cancer.
    Park HJ; Kim SR; Kim SS; Wee HJ; Bae MK; Ryu MH; Bae SK
    Oncotarget; 2014 Jul; 5(13):5087-99. PubMed ID: 24970818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling.
    Xing Z; Zhang M; Wang X; Liu J; Liu G; Feng K; Wang X
    J Mol Histol; 2021 Aug; 52(4):809-821. PubMed ID: 34009515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling.
    Wang X; Su D; Qin Z; Chen Z
    Gene; 2020 Jan; 722():144057. PubMed ID: 31430519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA anti-differentiation non-coding RNA affects proliferation, invasion, and migration of breast cancer cells by targeting miR-331.
    Jiang C; Shi X; Yi D; Wang R; Xu F; Guan W; Sang J
    Bioengineered; 2021 Dec; 12(2):12236-12245. PubMed ID: 34783641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TSP2 acts as a suppresser of cell invasion, migration and angiogenesis in medulloblastoma by inhibiting the Notch signaling pathway.
    Pan W; Song XY; Hu QB; Zhang M; Xu XH
    Brain Res; 2019 Sep; 1718():223-230. PubMed ID: 31063715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asiatic Acid Interferes with Invasion and Proliferation of Breast Cancer Cells by Inhibiting WAVE3 Activation through PI3K/AKT Signaling Pathway.
    Gou XJ; Bai HH; Liu LW; Chen HY; Shi Q; Chang LS; Ding MM; Shi Q; Zhou MX; Chen WL; Zhang LM
    Biomed Res Int; 2020; 2020():1874387. PubMed ID: 32104680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer.
    Zhang W; Veisaga ML; Barbieri MA
    Exp Cell Res; 2020 Nov; 396(2):112318. PubMed ID: 33069695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity induced a leptin-Notch signaling axis in breast cancer.
    Battle M; Gillespie C; Quarshie A; Lanier V; Harmon T; Wilson K; Torroella-Kouri M; Gonzalez-Perez RR
    Int J Cancer; 2014 Apr; 134(7):1605-16. PubMed ID: 24114531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer.
    Izrailit J; Berman HK; Datti A; Wrana JL; Reedijk M
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1714-9. PubMed ID: 23319603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer.
    Kumar S; Srivastav RK; Wilkes DW; Ross T; Kim S; Kowalski J; Chatla S; Zhang Q; Nayak A; Guha M; Fuchs SY; Thomas C; Chakrabarti R
    Oncogene; 2019 Mar; 38(12):2092-2107. PubMed ID: 30442981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progranulin stimulated by LPA promotes the migration of aggressive breast cancer cells.
    Swamydas M; Nguyen D; Allen LD; Eddy J; Dréau D
    Cell Commun Adhes; 2011 Dec; 18(6):119-30. PubMed ID: 22176685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study on Notch signaling in human breast cancer.
    Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D
    Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of BMP9 on breast cancer cells by regulating their interaction with pre-adipocytes/adipocytes.
    Wang T; Zhang Z; Wang K; Wang J; Jiang Y; Xia J; Gou L; Liu M; Zhou L; He T; Zhang Y
    Oncotarget; 2017 May; 8(22):35890-35901. PubMed ID: 28415788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
    Normanno N; De Luca A; Maiello MR; Campiglio M; Napolitano M; Mancino M; Carotenuto A; Viglietto G; Menard S
    J Cell Physiol; 2006 May; 207(2):420-7. PubMed ID: 16419029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer.
    Guo S; Gonzalez-Perez RR
    PLoS One; 2011; 6(6):e21467. PubMed ID: 21731759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation of DACT2 promotes breast cancer development by activating Wnt signaling.
    Li J; Zhang M; He T; Li H; Cao T; Zheng L; Guo M
    Sci Rep; 2017 Jun; 7(1):3325. PubMed ID: 28607412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the Jagged/Notch pathway inhibits retinoblastoma cell proliferation via suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β‑catenin signaling pathways.
    Xiao W; Chen X; He M
    Mol Med Rep; 2014 Jul; 10(1):453-8. PubMed ID: 24805975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.